Connect with us

Resources

How private sector ingenuity helps protect Covid-19 vaccines

Published

on

les vaccins Covid 19

The development of Covid-19 vaccines has led to unprecedented cooperation between public and private health. However, this came with a series of challenges. The leading cause of these difficulties lies in the transport and packaging of vaccines. These issues became significant around the world after it was first released at the end of December 2020.

The stringent demands placed on these highly temperature-sensitive vaccines have resulted in inevitable product losses (these temperature-controlled vaccines regularly cause wastage) as authorities around the world report a surprisingly high number of spoiled vaccines due to breakage of the cold chain.

One way to overcome these challenges is to improve existing supply chains to focus on precise temperature control, cold chain monitoring, and data logging. This will help preserve the integrity of vaccines, save money and provide better treatments for patients.

The private sectors are currently working with the public health sectors to address these challenges. They are working at a very rapid pace to ensure that they are addressing these issues. The rate at which they operate and do research is improving now as they have successfully developed innovative ideas. Some of these ideas have been tested and found to effectively control the pandemic and potentially save lives.

The private sector is now working on vaccine protection

Faced with the ongoing challenges of transporting and packaging Covid-19 vaccines, the private sector is now working with the government to find a stable solution. Logmore recently launched a data logging system called Logmore Dry Ice to improve cold chain efficiency Logmore Dry Ice is an adaptation of the company’s original data logging system. The device monitors numerous status measurements during shipment transit, even at temperatures of -100 ° C. It also uses an innovative, dynamic display of QR codes to synchronize and access this data from any smartphone.

Logmore Dry Ice is able to monitor shipments of sensitive frozen products, aiding in quality assurance as the Covid-19 vaccine travels around the world. Sofrigam, a cold chain specialist based in France, also offers profitable solutions. These are its Elite Cubic and Initial Freight Forwarding reusable parcel shippers for batch vaccine shipments. These cartons are highly insulated thanks to high thermal performance and impact-resistant materials. They are able to maintain vaccine shipments at temperatures as low as -80 ° C for 168 hours (seven days) using dry ice.

In addition, larger consignments can be transported using the Sofrigam Initial Pallet Shippers. It can be maintained at cold chain temperatures ranging from -80 ° C to -20 ° C for up to 120 hours ( five days). This is more than sufficient for most air cargo applications.

Sofrigam also supplies a wide range of insulated bags and pouches for the distribution and delivery of refrigerated vaccines on the “last mile” of the cold chain.

“The partnership with Logmore is the logical continuation of our promise to our customers and the end-user. Our mission is to provide medical and health actors with peace of mind about the effectiveness of vaccines while meeting the demands of global demand for Covid-19 vaccination initiatives”, states Laurence Labranque, vice-president of Sofrigam.

The private sector brings more expertise

The private sector’s contribution to the logistics of Covid-19 vaccines has helped attract more experts in logistics management and pharmaceuticals. Logmore and Sofrigam have implemented innovative technology thanks to the talented experts who are part of their team. The two companies are working together to make vaccines easily accessible to end-users around the world. Their products have been tested and prequalified in a thermal testing laboratory according to the required standards. The logistics solutions of both companies were also recognized as being among the most efficient on the market.

In response to the Covid-19 pandemic, Sofrigam announced that it had put in place a determined action program to deal with the Covid-19 crisis. It then carried out a series of collective actions that enabled it to maintain the production and supply of its temperature-controlled packaging, shipping, and last-mile logistics solutions. The program called for creating a crisis support team that now meets regularly to monitor the latest developments in the CV-19 pandemic and initiate appropriate actions. The company initially specialized in passive packaging but is now moving towards innovative active technologies. The synergy between the two companies represents a major innovation in the field of cold production and storage.

Together with Logmore, they aim to ensure the safe and secure transport of vaccines around the world. They believe this will help find a lasting solution for the virus. It will also contribute to the development necessary to fight the virus.

Covid-19 is one of the most resilient viruses the world has ever known, and it takes a high level of experience and expertise to bring it under control. The private sector is doing its best to ensure a safe environment for the people. It will help us build a good future where people can lead healthy lives without being afraid of Covid-19.

I'm a passionate full-time blogger. I love writing about startups, how they can access key resources, avoid legal mistakes, respond to questions from angel investors as well as the reality check for startups. Continue reading my articles for more insight.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Newsletter


Advertisement

Top of the month